Aortic valve replacement in a patient with sickle cell disease-Are we justified to perform surgery in the TAVI era?

Ramanish Ravishankar; Leenah Turkistani; Yasser Elghoneimy; Imthiaz Manoly

doi:10.1002/ccr3.4085

Aortic valve replacement in a patient with sickle cell disease-Are we justified to perform surgery in the TAVI era?

Clin Case Rep. 2021 Mar 29;9(8):e04085. doi: 10.1002/ccr3.4085. eCollection 2021 Aug.

Authors

Ramanish Ravishankar¹, Leenah Turkistani², Yasser Elghoneimy², Imthiaz Manoly³

Affiliations

¹ University of Edinburgh Edinburgh UK.
² Imam Abdulrahman Bin Faisal University Dammam Saudi Arabia.
³ Department of Cardiothoracic Surgery James Cook University Hospital Middlebrough UK.

Abstract

Not all variants of SCD need the same management and this should be decided on a case-by-case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.

Keywords: cardiopulmonary bypass; cardiothoracic surgery; hemotology; sickle cell disease.

Publication types

Case Reports